Catalyst
Most analysts rate DOC Buy or Strong Buy, showing broad institutional optimism.
Risk
Technical indicators show that the market is in a volatile state, and the direction is not clear enough.
Zota Health Care reported a consolidated net loss of Rs 12.89 crore in the March 2025 quarter.
Generated at04:2012/07/2025by
Aime
